Is ARMS2 p.Ala79Asp (c.236C>A) pathogenic?

ARMS2 p.Ala79Asp (c.236C>A) is classified Uncertain significance in ARMS2 (ClinVar, Single submitter, 1 submitter; last evaluated 2025-01-19). AlphaMissense: likely benign (0.2143); Ultra-rare (popmax 0.0521%, afr).

How common is ARMS2 p.Ala79Asp (c.236C>A) in the general population?

ARMS2 p.Ala79Asp (c.236C>A) is ultra-rare (popmax 0.0521%, afr) (gnomAD).

What do computational predictors say about ARMS2 p.Ala79Asp (c.236C>A)?

AlphaMissense predicts likely benign (score 0.2143) — an in-silico prediction, not a clinical call.

ARMS2 p.Ala79Asp

c.236C>A · VCV3786500

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.2143 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0521%, afr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.2143	likely benign
REVEL	0.064	moderately benign-leaning
SaProt	LLR -6.67	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -3.7	GERP -1.6
Regional constraint	o/e 0.78	unconstrained · MANE · 2,202 bp · p 0.011 · regional, not allelic
Overall
CADD	1.308	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0521% African / African-American · 39/74,888 alleles

Filtering AF 0.0392% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0346%

Overall 0.00347% 56/1,613,664 alleles · ultra-rare

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.0521%	1,920
Remaining individualsnot grpmax-eligible	0.0176%	5,679
Admixed American	0.00667%	14,997
European (non-Finnish)	0.00017%	589,877

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: ARMS2
Protein: p.Ala79Asp
Coding: c.236C>A
MANE Select: NM_001099667
Type: single nucleotide variant
Location: chr10:122454963 (GRCh38)
Gene constraint: LOEUF 1.815 · pLI 0.02 (gnomAD)
Structure: AlphaFold pLDDT 58.14

Full ARMS2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

ARMS2 c.298-13A>G Benign/Likely benign ★★ same type
ARMS2 c.298-13A>T Benign/Likely benign ★★ same type
ARMS2 c.*107T>G Likely benign ★★ same type
ARMS2 c.*373T>G Benign/Likely benign ★★ same type
ARMS2 c.*45T>G Likely benign ★★ same type
ARMS2 p.Ala69Ser Benign ★★ same type
ARMS2 p.Arg38Ter Benign ★★ same type
ARMS2 c.*251T>C Uncertain significance ★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/arms2-p-ala79asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown